Roche Analyst Event at ASCO 2019

Roche has hosted an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).

Agenda:

  • Welcome
    Karl Mahler, Head of Investor Relations
  • ASCO 2019 Key readouts across tumor types
    Hematology
    Nancy Valente, M.D., Global Head of Product Development - Hematology
    Breast cancer, lung cancer & pan-tumor
    Alan Sandler, M.D., Global Head of Product Development - Solid Tumors
  • Roche Oncology strategy update
    Bill Anderson, CEO Roche Pharmaceuticals
  • Q&A

Please register to access the webcast

* Mandatory

 

The registration form for the webcast is not available.

 

Please come back 30 minutes before the webcast start date and fill in the registration form.